SCHEMBL3938801

SCHEMBL3938801

CCOc1ccc(/C(=C\C=C\C(=O)O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.56
PARP10 Q53GL7 1/20 0.49
MAOA P21397 2/20 0.46
MAPT P10636 3/20 0.45
LMNA P02545 1/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
PLA2G4B P0C869 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
GABRB2 P47870 1/20 0.44
GABRA4 P48169 1/20 0.44
GABRA6 Q16445 1/20 0.44
NR4A2 P43354 1/20 0.43
NPC1 O15118 2/20 0.43
PLK1 P53350 1/20 0.43
CHRNA7 P36544 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3938809 1.00 MAOB (0.56) MAOBPARP10MAOAMAPTLMNA
SCHEMBL3938811 1.00 MAOB (0.56) MAOBPARP10MAOAMAPTLMNA
SCHEMBL3938861 0.93 PARP10 (0.56) MAOBPARP10MAOAMAPTPLA2G4B
SCHEMBL3938871 0.93 PARP10 (0.56) MAOBPARP10MAOAMAPTPLA2G4B
SCHEMBL3948430 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTLMNA
SCHEMBL3948433 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTLMNA
SCHEMBL3947567 0.88 MAOB (0.56) MAOBPARP10MAOAMAPTLMNA
SCHEMBL10399085 0.84 ALOX15 (0.48) MAOBMAPTLMNAALDH1A1
SCHEMBL3945842 0.84 ALOX15 (0.48) MAOBMAPTLMNAALDH1A1
SCHEMBL3945845 0.84 ALOX15 (0.48) MAOBMAPTLMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-08-13 US disclosed
EP-2050734-A1 PENTADIENAMIDE DERIVATIVE Kyowa Hakko Kirin Co., Ltd. (JP) 2009-04-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203667-A1 PENTADIENAMIDE DERIVATIVES PRMT1, REN, NGLY1 MAOB 747/4885PARP10 1526/4885MAOA 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.